Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S

Slides:

Advertisements

Similar presentations

Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.

Advertisements

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Incorporating big data into treatment plan evaluation: Development of statistical DVH metrics and visualization dashboards Charles S. Mayo, PhD, John.

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy Dawn Owen, MD, PhD, Charles S. Mayo, PhD,

Chad G. Rusthoven, MD, Christine F. Lauro, MD, Brian D

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases Isabelle Thibault, MD, Mikki Campbell,

Dosimetric and Economic Comparison of Interstitial High-Dose-Rate Brachytherapy to Stereotactic Body Radiation Therapy for Liver Lesions Brian A. Hrycushko,

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and.

A Pain in the Neck: Thyroid Abscess

Should we irradiate a brain tumor in a patient with parkinsonism

William L. Lanier, MD Mayo Clinic Proceedings

RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results Samuel Ryu, MD, Stephanie L.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization

Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer Matthew J. Furman, MD, Giles F. Whalen, MD,

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary Lawrence B. Marks, MD, Robert.

Brenda G. Clark, PhD, Robert J

Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc

Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals Chirag Shah, MD, Larry L. Kestin,

Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree Justin M. Haseltine, BSE,

Safety of differential radiation dosing in lymph node positive necks treated with IMRT Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

My Path from Hiroshima to Houston

Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer Nancy El-Bared, MD,

Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,

Should we irradiate a brain tumor in a patient with parkinsonism

Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma Amanda J. Walker, MD, Alin Chirindel, MD, Robert.

Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality.

Phantom Verification of AAA and Acuros Dose Calculations for Lung Cancer: Do Tumor Size and Regression Matter? Satomi Shiraishi, PhD, Luis E. Fong de.

Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer Max Dahele, MBChB, MSc, David Palma, MD, Frank Lagerwaard, MD, PhD, Ben Slotman,

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.

American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing.

Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience Corey J. Hobbs, MD, Stephen.

Follow-Up of Patients after Stereotactic Radiation for Lung Cancer: A Primer for the Nonradiation Oncologist Kitty Huang, MSc, MDCM, David A. Palma,

Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C- Choline Positron Emission and Computed Tomography Tyler Trump, BS,

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning.

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J

Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma

An Editorial Note: The Long Arm of Practical Radiation Oncology

The role of positron emission tomography for non-small cell lung cancer Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD Practical.

Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey Hannah Dahn, MD, Angela McGibbon, MD, David.

Safety considerations for IMRT: Executive summary

Proton SBRT for Medically Inoperable Stage I NSCLC

Khaled Adil, MD, Marija Popovic, PhD, Fabio L. Cury, MD, Sergio L

Safety Profile Assessment: An online tool to gauge safety-critical performance in radiation oncology Peter Dunscombe, PhD, Derek Brown, PhD, Holly Donaldson,

Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American.

Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer.

Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability Prashant Gabani, MD, Benjamin W.

Radiation recall precipitated by iodinated nonionic contrast

Pain Response Rates After Conventional Radiation Therapy for Bone Metastases in Prospective Nonrandomized Studies: A Systematic Review Tetsuo Saito,

Gaurav Marwaha, MD, Kevin L. Stephans, MD, Neil M

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD

Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018 Thomas M. Pisansky, MD, Ian M. Thompson,

Inadequate colonoscopy preparation: Is it time to send out an SMS?

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Stereotactic Body Radiotherapy for Central Lung Tumors

A Review of First-Line Treatment for Small-cell Lung Cancer

Presentation transcript:

Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S. Mayo, PhD, Yolanda I. Garces, MD, Sean S. Park, MD, PhD, Heather J. Bauer, RN, CNP, Kathryn Nelson, RN, Robert W. Miller, MD, Paul D. Brown, MD, Kenneth R. Olivier, MD Practical Radiation Oncology Volume 4, Issue 2, Pages e143-e149 (March 2014) DOI: 10.1016/j.prro.2013.05.006 Copyright © 2014 American Society for Radiation Oncology Terms and Conditions

Figure 1 Axial slice of stereotactic body radiation therapy (SBRT) bone plan. Red corresponds to the 24 Gy line and blue corresponds to the 18 Gy line. SBRT plan of the left ischium. Practical Radiation Oncology 2014 4, e143-e149DOI: (10.1016/j.prro.2013.05.006) Copyright © 2014 American Society for Radiation Oncology Terms and Conditions